MedTrace Logo

ASCO Survey on COVID-19 in Oncology (ASCO) Registry

NCT04659135 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 7000

Last updated 2023-07-24

No results posted yet for this study

Summary

The American Society of Clinical Oncology (ASCO) Survey on Coronavirus 2019 (COVID-19) in Oncology Registry (ASCO Registry) aims to help the cancer community learn more about the patterns of symptoms and severity of COVID-19 among patients with cancer, as well as how COVID-19 is impacting the delivery of cancer care and patient outcomes. The ASCO Registry collects both baseline and follow-up data on how the virus impacts cancer care and cancer patient outcomes during the COVID-19 pandemic.

Conditions

  • Neoplasms
  • Coronavirus

Sponsors & Collaborators

Principal Investigators

  • Julie R Gralow, MD · American Society of Clinical Oncology

  • Suanna S Bruinooge, MPH · American Society of Clinical Oncology

  • Elizabeth Garrett-Mayer, PhD · American Society of Clinical Oncology

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-19
Primary Completion
2024-08-31
Completion
2025-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04659135 on ClinicalTrials.gov